Arzoxifene
Arzoxifene
Arzoxifene (pronounced: ar-zox-i-feen) is a Selective Estrogen Receptor Modulator (SERM) that is primarily used in the treatment of breast cancer and osteoporosis. It is a derivative of tamoxifen, another SERM that is commonly used in breast cancer treatment.
Etymology
The term "Arzoxifene" is derived from the chemical structure of the drug. The prefix "Ar" is derived from the word "aryl", which refers to the aromatic ring structure present in the molecule. The "zox" part of the name is derived from the presence of a "zoxazol" ring in the molecule. The suffix "ifene" is common in the names of SERMs and is derived from the word "phenyl", another term for an aromatic ring.
Usage
Arzoxifene is used in the treatment of estrogen receptor-positive breast cancer, a type of breast cancer that grows in response to the hormone estrogen. It works by blocking the effects of estrogen in the breast tissue, thereby slowing or stopping the growth of cancer cells.
In addition to its use in breast cancer treatment, Arzoxifene is also used to treat and prevent osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in the bone tissue, which helps to maintain bone density and prevent fractures.
Related Terms
External links
- Medical encyclopedia article on Arzoxifene
- Wikipedia's article - Arzoxifene
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski